Redbiotec AG
Therapeutic bacteria for treating cancer & genetic disorders
Redbiotec develops therapeutic bacteria to treat cancer and genetic disorders. Designed to overcome delivery hurdles faced by other vehicles, the proprietary bacteria platform accommodates large and diverse therapeutic cargos ranging from oncolytic virus to gene editing system. The company builds upon its teams expertise in microbial engineering and immunology. During its era as a vaccine innovator, Redbiotec has sold its CMV vaccine business to Pfizer in 2015 and also created an HSV-2 immunotherapy.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
14.04.2020
Biotech Startup Redbiotec's CEO Christian Schaub About Inspiring and Leading a Team (venturelab.swiss)
09.04.2020
Smart answers to the corona virus (startupticker.ch)
05.01.2015
Pfizer Acquires Spin-off from Redbiotec (startupticker.ch)
28.07.2014
Redbiotec and GE Healthcare Collaborate (startupticker.ch)
11.07.2014
Encouraging results for Redbiotec (startupticker.ch)
Last Tweets
12.09.2012
No Jobs
No videos and documents
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
>>Venture>>
The venture business plan competition takes place every year and combines a competition, learning events and contact form in one. It is an initiative of the ETH Zurich, CTI and McKinsey.
ETH Spin-off
http://www.vpf.ethz.ch/transfer/firmgruend/spinoff_list/by_years/2009
SEF High Potential SME
The Growth Initiative is based on a review of the growth strategy and the award of the Swiss Economic Forum’s “High-Potential SME” quality label. The qualification process is a progressive four-stage selection procedure and is free for the participating company.
Volkswirtschaft-Stiftung
Die eidgenössische Stiftung zur Förderung schweizerischer Volkswirtschaft durch wissenschaftliche Forschung bezweckt die Förderung des Technologietransfers. Jungunternehmen können sich für ein zinsloses Darlehen bewerben.
Redbiotec AG
Therapeutic bacteria for treating cancer & genetic disorders
Website:
www.redbiotec.ch
Pfizer
Headquarter:
Schlieren
Foundation Date:
November 2006
Technology:
- Biotech
Sectors:
- Biotech
- Cancer
- Drug development platforms
- Drug discovery
- Research and development
- Protein drugs
- Vaccines
Support received
